For a 52-year-old woman on methimazole 10 mg daily for one month for hyperthyroidism, should I order thyroid stimulating hormone, free thyroxine, aspartate aminotransferase, alanine aminotransferase, a complete blood count with differential, a fasting lipid panel, and review her home glucose logs?

Monitoring Methimazole Therapy: Essential Laboratory Testing at One Month

Yes, these are the appropriate labs to order, with one critical addition: you must include a complete blood count (CBC) with differential to screen for agranulocytosis, a potentially life-threatening complication of methimazole therapy.

Core Monitoring Requirements for Methimazole at One Month

Thyroid Function Assessment

• TSH and free T4 are essential to evaluate treatment response and adjust methimazole dosing, as the drug can cause hypothyroidism requiring routine monitoring to maintain a euthyroid state 1
• Methimazole readily crosses placental membranes and can cause fetal goiter and cretinism, making it critical to use a sufficient but not excessive dose 1
• At one month, you're assessing whether the 10 mg daily dose is achieving adequate thyroid suppression without inducing iatrogenic hypothyroidism 1

Hepatotoxicity Surveillance (ALT, AST)

• Liver enzyme monitoring is mandatory because methimazole can cause hepatotoxicity, including acute liver failure, though the risk is lower than with propylthiouracil 1
• The FDA label explicitly states that symptoms of hepatic dysfunction (anorexia, pruritus, right upper quadrant pain) should prompt evaluation of liver function (bilirubin, alkaline phosphatase) and hepatocellular integrity (ALT, AST) 1
• Drug treatment should be discontinued promptly if hepatic transaminase values exceed 3 times the upper limit of normal 1
• Methimazole-induced cholestatic jaundice can occur within the first few weeks of therapy and is severe but reversible upon discontinuation 2, 3
• A baseline assessment of liver function before starting antithyroid drug treatment is recommended, with regular monitoring during therapy 4

Critical Missing Test: Complete Blood Count with Differential

• You must add a CBC with differential to screen for agranulocytosis, which is potentially life-threatening and occurs in 0.1 to 0.5% of patients on thionamides 1, 5
• Patients should be instructed to immediately report fever or sore throat, as these are suggestive symptoms of agranulocytosis 1
• Leukopenia, thrombocytopenia, and aplastic anemia (pancytopenia) may also occur, requiring drug discontinuation and bone marrow monitoring 1
• The most dangerous adverse effect of methimazole is agranulocytosis, which can now be effectively treated with granulocyte colony-stimulating factor if detected early 5

Additional Appropriate Tests

Fasting Lipid Panel

• The lipid panel is reasonable because you're planning to assess for statin initiation once thyroid function stabilizes 6
• Hyperthyroidism affects lipid metabolism, and normalizing thyroid function will alter the lipid profile, making it appropriate to establish a baseline once euthyroid 6
• TSH levels >10 mIU/L are associated with hypertriglyceridemia and elevated LDL cholesterol, so correcting hyperthyroidism may improve lipids before considering statin therapy 6

Home Glucose Log Review

• Reviewing glucose logs is appropriate because thyroid control improves insulin sensitivity, potentially increasing hypoglycemia risk in patients with diabetes 6
• As hyperthyroidism is corrected, metabolic rate decreases and insulin sensitivity increases, requiring adjustment of diabetes medications to prevent hypoglycemia 6

Monitoring Timeline and Follow-Up

• Recheck thyroid function tests (TSH, free T4) at 6-8 week intervals while titrating methimazole dose to achieve target euthyroid state 6
• Once adequately treated, repeat testing every 6-12 months or if symptoms change 6
• Free T4 helps interpret ongoing abnormal TSH levels during therapy, as TSH may take longer to normalize 6

Common Pitfalls to Avoid

• Never skip the CBC with differential at baseline and during early therapy—agranulocytosis can be life-threatening but is treatable if caught early 1, 5
• Don't wait for symptoms to check liver enzymes—hepatotoxicity can occur within the first few weeks and requires prompt discontinuation 1, 4, 2, 3
• Avoid adjusting doses too frequently before reaching steady state; methimazole has an elimination half-life of 4.9-5.7 hours, requiring adequate time between adjustments 7
• Don't overlook the need for patient education about immediately reporting fever, sore throat, jaundice, pruritus, or right upper quadrant pain 1

Summary of Recommended Laboratory Panel

1. TSH and free T4 (already planned) ✓
2. ALT and AST (already planned) ✓
3. Complete blood count with differential (MUST ADD) ✗
4. Fasting lipid panel (already planned) ✓
5. Review home glucose logs (already planned) ✓

The 8-12 hour fasting instruction is appropriate for the lipid panel and any fasting glucose measurement.